Beatson West of Scotland Cancer Centre - Academic Profile

Publications

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

Masatoshi Kudo , Richard S. Finn , Shukui Qin +19 more

2018 The Lancet 5118 citations

Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Robert J. Motzer , Konstantin Penkov , John B.A.G. Haanen +25 more

Progression-free survival was significantly longer with avelumab plus axitinib than with sunitinib among patients who received these agents as first-line treatment for advanced ...

2019 New England Journal of Medicine 2439 citations

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

W.K. Alfred Yung , Robert E. Albright , Jeffrey J. Olson +19 more

A randomized, multicentre, open-label, phase II study compared temozolomide (TMZ), an oral second-generation alkylating agent, and procarbazine (PCB) in 225 patients with gliobl...

2000 British Journal of Cancer 929 citations

Affiliated Researchers

Institution Info

Type: healthcare
Country: GB
Publications: 3
Citations: 8,486

External Links

Identifiers

ROR: https://ror.org/03pp86w19